BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 24452533)

  • 1. Molecular profiling of chordoma.
    Scheil-Bertram S; Kappler R; von Baer A; Hartwig E; Sarkar M; Serra M; Brüderlein S; Westhoff B; Melzner I; Bassaly B; Herms J; Hugo HH; Schulte M; Möller P
    Int J Oncol; 2014 Apr; 44(4):1041-55. PubMed ID: 24452533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Novel molecular aspects of chordomas].
    Scheil-Bertram S
    Pathologe; 2014 Nov; 35 Suppl 2():237-41. PubMed ID: 25394972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chordoma and chondrosarcoma gene profile: implications for immunotherapy.
    Schwab JH; Boland PJ; Agaram NP; Socci ND; Guo T; O'Toole GC; Wang X; Ostroumov E; Hunter CJ; Block JA; Doty S; Ferrone S; Healey JH; Antonescu CR
    Cancer Immunol Immunother; 2009 Mar; 58(3):339-49. PubMed ID: 18641983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of chordoma cell line JHC7 and the identification of Brachyury as a novel molecular target.
    Hsu W; Mohyeldin A; Shah SR; ap Rhys CM; Johnson LF; Sedora-Roman NI; Kosztowski TA; Awad OA; McCarthy EF; Loeb DM; Wolinsky JP; Gokaslan ZL; Quiñones-Hinojosa A
    J Neurosurg; 2011 Oct; 115(4):760-9. PubMed ID: 21699479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brachyury gene copy number gain and activation of the PI3K/Akt pathway: association with upregulation of oncogenic Brachyury expression in skull base chordoma.
    Otani R; Mukasa A; Shin M; Omata M; Takayanagi S; Tanaka S; Ueki K; Saito N
    J Neurosurg; 2018 May; 128(5):1428-1437. PubMed ID: 28753115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brachyury, SOX-9, and podoplanin, new markers in the skull base chordoma vs chondrosarcoma differential: a tissue microarray-based comparative analysis.
    Oakley GJ; Fuhrer K; Seethala RR
    Mod Pathol; 2008 Dec; 21(12):1461-9. PubMed ID: 18820665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An integrated functional genomics approach identifies the regulatory network directed by brachyury (T) in chordoma.
    Nelson AC; Pillay N; Henderson S; Presneau N; Tirabosco R; Halai D; Berisha F; Flicek P; Stemple DL; Stern CD; Wardle FC; Flanagan AM
    J Pathol; 2012 Nov; 228(3):274-85. PubMed ID: 22847733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the transcription factor T (brachyury) in the pathogenesis of sporadic chordoma: a genetic and functional-based study.
    Presneau N; Shalaby A; Ye H; Pillay N; Halai D; Idowu B; Tirabosco R; Whitwell D; Jacques TS; Kindblom LG; Brüderlein S; Möller P; Leithner A; Liegl B; Amary FM; Athanasou NN; Hogendoorn PC; Mertens F; Szuhai K; Flanagan AM
    J Pathol; 2011 Feb; 223(3):327-35. PubMed ID: 21171078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome-wide analysis of sixteen chordomas by comparative genomic hybridization and cytogenetics of the first human chordoma cell line, U-CH1.
    Scheil S; Brüderlein S; Liehr T; Starke H; Herms J; Schulte M; Möller P
    Genes Chromosomes Cancer; 2001 Nov; 32(3):203-11. PubMed ID: 11579460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brachyury and chordoma: the chondroid-chordoid dilemma resolved?
    Romeo S; Hogendoorn PC
    J Pathol; 2006 Jun; 209(2):143-6. PubMed ID: 16604512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrent loss of chromosome 22 and SMARCB1 deletion in extra-axial chordoma: A clinicopathological and molecular analysis.
    Wen X; Cimera R; Aryeequaye R; Abhinta M; Athanasian E; Healey J; Fabbri N; Boland P; Zhang Y; Hameed M
    Genes Chromosomes Cancer; 2021 Dec; 60(12):796-807. PubMed ID: 34392582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular characterization of chordoma xenografts generated from a novel primary chordoma cell source and two chordoma cell lines.
    Karikari IO; Gilchrist CL; Jing L; Alcorta DA; Chen J; Richardson WJ; Gabr MA; Bell RD; Kelley MJ; Bagley CA; Setton LA
    J Neurosurg Spine; 2014 Sep; 21(3):386-93. PubMed ID: 24905390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular and clinical risk factors for recurrence of skull base chordomas: gain on chromosome 2p, expression of brachyury, and lack of irradiation negatively correlate with patient prognosis.
    Kitamura Y; Sasaki H; Kimura T; Miwa T; Takahashi S; Kawase T; Yoshida K
    J Neuropathol Exp Neurol; 2013 Sep; 72(9):816-23. PubMed ID: 23965741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. P63 does not regulate brachyury expression in human chordomas and osteosarcomas.
    Pillay N; Amary FM; Berisha F; Tirabosco R; Flanagan AM
    Histopathology; 2011 Nov; 59(5):1025-7. PubMed ID: 22007675
    [No Abstract]   [Full Text] [Related]  

  • 15. Targeted brachyury degradation disrupts a highly specific autoregulatory program controlling chordoma cell identity.
    Sheppard HE; Dall'Agnese A; Park WD; Shamim MH; Dubrulle J; Johnson HL; Stossi F; Cogswell P; Sommer J; Levy J; Sharifnia T; Wawer MJ; Nabet B; Gray NS; Clemons PA; Schreiber SL; Workman P; Young RA; Lin CY
    Cell Rep Med; 2021 Jan; 2(1):100188. PubMed ID: 33521702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T gene isoform expression pattern is significantly different between chordomas and notochords.
    Wang K; Hu Q; Wang L; Chen W; Tian K; Cao C; Wu Z; Jia G; Zhang L; Zeng C; Zhang J
    Biochem Biophys Res Commun; 2015 Nov; 467(2):261-7. PubMed ID: 26435504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 'The chicken or the egg?' dilemma strikes back for the controlling mechanism in chordoma(#).
    Szuhai K; Hogendoorn PC
    J Pathol; 2012 Nov; 228(3):261-5. PubMed ID: 22952146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel therapeutic targets in chordoma.
    Bydon M; Papadimitriou K; Witham T; Wolinsky JP; Bydon A; Sciubba D; Gokaslan Z
    Expert Opin Ther Targets; 2012 Nov; 16(11):1139-43. PubMed ID: 22860993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Afatinib Is a New Therapeutic Approach in Chordoma with a Unique Ability to Target EGFR and Brachyury.
    Magnaghi P; Salom B; Cozzi L; Amboldi N; Ballinari D; Tamborini E; Gasparri F; Montagnoli A; Raddrizzani L; Somaschini A; Bosotti R; Orrenius C; Bozzi F; Pilotti S; Galvani A; Sommer J; Stacchiotti S; Isacchi A
    Mol Cancer Ther; 2018 Mar; 17(3):603-613. PubMed ID: 29237806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic aberrations and molecular biology of skull base chordoma and chondrosarcoma.
    Kitamura Y; Sasaki H; Yoshida K
    Brain Tumor Pathol; 2017 Apr; 34(2):78-90. PubMed ID: 28432450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.